- wöchentlichErscheinungsrhythmus
- 55 mintypische Länge
- vor 3 Tagenletzte Folge
Folgenzu den neuesten
BoB@JPM: Peter Anastasiou, Capsida Biotherapeutics
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) From the JP Morgan Healthcare Conference in San Francisco, Peter Anastasiou, CEO of Capsida Biotherapeutics, discusses his journey from
BoB@JPM: Stefan Scherer, M.D., Ph.D., 3T Bioscience
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) From the JP Morgan Healthcare Conference in San Francisco, Dr. Stefan Scherer shares insight from 3T Bioscience's transition from clini
The Business Of CNS with Acumen's Jim Doherty, Ph.D.
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) Life Science Leader's Ben Comer and Acumen Pharmaceuticals' Dr. Jim Doherty join the Business of Biotech to discuss Dr. Doherty's lifel
High-Throughput Discovery With Bioptic's Andrey Dobry
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) Andrey Doronichev, known to many simply as Dobry, is perhaps best known for taking YouTube mobile. You heard that right. If it weren't
RNA Sandbox with Johns Hopkins RNA Innovation Center's Jeff Coller, Ph.D. and Michelle Kim, Ph.D.
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) In close partnership woth Johns Hopkins and TriLink BioTechnologies, Jeff Coller, Ph.D. and Michelle Kim, Ph.D. have built a sandbox fo
Biotech Story Time With Tal Zaks, M.D. (Part 2, Tall Tales with Tal)
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) Dr. Tal Zaks is back, along with Advancing RNA's Anna Rose Welch, for part 2 of "Story Time With Tal." On this week's episode, we turn
Risk Mitigation With Meira GTx's Zandy Forbes, Ph.D.
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) Zandy Forbes, Ph.D. learned about business risk mitigation in the riskiest of business environments. She was a public markets healthcar
Biotech Story Time With Tal Zaks, M.D. (Part 1)
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) Tal Zaks, M.D. was Chief Medical Officer at Moderna before, during, and immediately following the company's headline role during the CO
A $1B AI Bet With Foresite Labs' Vik Bajaj, Ph.D.
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) This past spring, Xaira Therapeutics launched with $1 billion in backing, a who's-who mashup of Silicon Valley and biopharma stars led
Manufacturing Partnership With Life Biosciences' Jerry McLaughlin and Forge Biologics' John Maslowski
We love to hear from our listeners. Send us a message. (https://www.buzzsprout.com/1011661/fan_mail/new) On this week's episode of the Business of Biotech, Jerry McLaughlin, CEO and President at Life Biosciences returns for a visit, and he
